Meta Pixel

News and Announcements

Elexsys wins Davos Energy Week Startup Finalist competition

  • Published January 18, 2021 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

eleXsys Energy, which provides renewable energy solutions to global energy grids, is proud to announce that it has won the Davos Energy Week Startup Finalist Competition in the Renewable Energy Category.

eleXsys Energy Executive Director, Richard Romanowski, pitched eleXsys to an impressive online audience for the contest. He focused on how eleXsys can contribute to accelerating the transition to a clean energy future by increasing the capacity of energy grids to host multiple times more distributed energy resources such as solar and wind energy.

eleXsys Energy had been taking part in presentations and discussions at Davos Energy Week, a three-day event drawing the attention of business leaders and government representatives to key issues and challenges in the global energy industry.

A video showcasing eleXsys Energy’s innovative technology platform can be found here.

Register Interest

About eleXsys Energy

eleXsys Energy trades in Australia as Planet Ark Power.

eleXsys® is an internationally award-winning technology solution to the challenge of voltage volatility created by increasing distributed energy resources competing to dispatch energy into energy grids. The ever-increasing popularity of solar PV, wind and other clean energy distributed resources will continue to create challenges for network operators around the world to provide ongoing safe and stable energy to consumers. eleXsys represents an important contribution to the stability solutions sought by network operators and their consumers, without the need for expensive network infrastructure upgrades.

In 2019, eleXsys Energy was the Start-Up Energy Transition Award Winner at the 2019 Energy Transition Awards hosted by the German Energy Agency (dena) and the World

Energy Council in the category of Intelligent Grids, Platforms and Cybersecurity.

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now